Zydus Cadila has received final approval from the US Food and Drug
Administration (USFDA) to market Liothyronine Sodium tablets USP, 5
mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory
filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-for-thyroid-drug/articleshow/80419090.cms
No comments:
Post a Comment